FDA Approved: GALLIUM GA-68 PSMA-11 — Supplemental Application (UCSF Radiopharmaceutical Facility)

View source ↗

Summary

The FDA approved a supplemental application for Gallium-68 PSMA-11 (Ga-68 Gozetotide), a PET radiopharmaceutical used to image prostate cancer, developed by UCS…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• GALLIUM GA-68 PSMA-11 (Gallium-68 gozetotide)

Snippet

SUPPL AP for GALLIUM GA-68 PSMA-11 (GALLIUM GA-68 GOZETOTIDE)